Managers / Q1 2026
Gildi - lifeyrissjodur
CIK 0002108148 · GUDRUNARTUN 1, REYKJAVIK, 105 · 003545154700
Summary
Gildi - Lifeyrissjodur reported $197M in U.S.-listed holdings across 2 positions for Q1 2026.
The portfolio is heavily concentrated: JBTM alone accounts for 67.4% of reported value.
The book was largely unchanged from Q4 2025.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 67.4% · $133M
- Other · 32.6% · $64M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| JBTMJBT MAREL CORPORATION | HELD | −42.2K | 1.07M | −$38M | $133M |
| OCULIS HOLDING AG | HELD | −17.6K | 2.43M | +$14M | $64M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | JBTMJBT MAREL CORPORATIONhistory → | COM | 67.38% | $133M | 1.07M |
| 2 | OCULIS HOLDING AG | ORDINARY SHARES | 32.62% | $64M | 2.43M |
Filing History
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.